Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Filings indexed 428 across all filing types
Latest filing 2023-05-16 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Board Meeting — VAISHALI PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 22-May-2023 to consider and approve the Quarterly Audited Financial results of the Company for the…
Regulatory Filings
2023-05-16 English
Board Meeting — Financial Results/Other business matters
Board/Management Information Classification · 95% confidence The document is a notice of a Board Meeting scheduled for May 22, 2023, to consider and approve audited annual financial results and other matters. It is addressed to the stock exchange and references compliance with SEBI regulations. The document does not contain the financial results or audit report itself but is an announcement of the upcoming board meeting where these will be considered. The document length is short (2090 characters) and serves as an intimation rather than a full report. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related corporate governance activities.
2023-05-15 English
Credit Rating
Audit Report / Information Classification · 95% confidence The document is a Credit Rating Certificate issued by CRISIL Limited for Vaishali Pharma Limited, dated April 12, 2023. It includes detailed information about the company's creditworthiness, grading history, business and management overview, financial profile, and other related data. The document is not an annual report, earnings release, or any other financial report but rather a credit rating report. It is a standalone report providing credit rating information, which aligns with the category of Audit Report / Information (AR) as it relates to creditworthiness and financial assessment by a rating agency. The document is substantive and detailed, not merely an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the best fit is Audit Report / Information (AR). FY 2022
2023-04-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate addressed to the National Stock Exchange of India Limited regarding Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2023. It is a letter confirming compliance and stating that the regulation is not applicable as all shares are in demat form. The document is short (2337 characters) and primarily serves as a certification or attestation rather than containing substantive financial data or a full report. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and not a full financial or quarterly report.
2023-04-10 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to the National Stock Exchange of India Limited regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015. It informs about the trading window closure period around the financial results announcement date. The document does not contain any financial data, detailed report, or results but is an announcement related to regulatory compliance and insider trading restrictions. It is also very short (1517 characters), indicating it is not a full report but a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS).
2023-03-31 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated February 28, 2023, announcing that Vaishali Pharma Limited has received overseas supply orders worth 73.85 million USD. It is addressed to the National Stock Exchange of India and includes details about the company's business and the significance of the order. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is primarily an announcement of a business development (receipt of a large supply order) rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update. It is a general corporate announcement about a significant business order. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-02-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.